Cargando...

Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects

BACKGROUND: Here, we aimed to investigate the pharmacokinetics of abacavir and carbovir triphosphate (CBV-TP) with darunavir/ritonavir 900/100 mg once daily or raltegravir 400 mg twice daily. METHODS: HIV-infected subjects on abacavir (600 mg once daily) underwent steady-state pharmacokinetic assess...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jackson, Akil, Moyle, Graeme, Dickinson, Laura, Back, David, Khoo, Saye, Taylor, Jessica, Gedela, Keerti, Abongomera, George, Gazzard, Brian, Boffito, Marta
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736319/
https://ncbi.nlm.nih.gov/pubmed/22267465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP1910
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!